Is Sensei Biotherapeutics Inc (SNSE) Stock a Smart Investment Tuesday?

Sensei Biotherapeutics Inc (SNSE) stock is lower by -85.27% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives SNSE stock a score of 35 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 3. SNSE's rank also includes a long-term technical score of 5.

SNSE has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on SNSE!

See Full SNSE Report

What's Happening with SNSE Stock Today

Sensei Biotherapeutics Inc (SNSE) stock is up 4.97% while the S&P 500 is lower by -0.38% as of 11:57 AM on Tuesday, May 31. SNSE has gained $0.09 from the previous closing price of $1.81 on volume of 40,978 shares. Over the past year the S&P 500 is lower by -1.42% while SNSE is lower by -85.27%. SNSE lost -$1.35 per share in the over the last 12 months. Click Here to get the full Stock Report for Sensei Biotherapeutics Inc stock.